Achieve Life Sciences (ACHV) News Today $3.17 -0.05 (-1.55%) Closing price 04:00 PM EasternExtended Trading$3.16 -0.01 (-0.44%) As of 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Here are Rogue Funds Updates on Achieve Life Sciences (ACHV)February 18 at 11:09 AM | msn.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Short Interest UpdateAchieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) was the target of a large decline in short interest in January. As of January 31st, there was short interest totalling 2,900,000 shares, a decline of 24.7% from the January 15th total of 3,850,000 shares. Based on an average daily trading volume, of 219,900 shares, the days-to-cover ratio is presently 13.2 days.February 14, 2025 | marketbeat.comAchieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences ConferenceFebruary 11, 2025 | globenewswire.comAchieve reports safe long-term cytisinicline exposureFebruary 10, 2025 | msn.comAchieve Life Sciences (ACHV) Gets a Buy from Lake StreetFebruary 10, 2025 | markets.businessinsider.comAchieve Life Sciences announces DSMC recently completed review of ORCA-OL trialFebruary 10, 2025 | markets.businessinsider.comAchieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical TrialFebruary 10, 2025 | globenewswire.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Short Interest Up 30.0% in JanuaryAchieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 3,810,000 shares, a growth of 30.0% from the December 31st total of 2,930,000 shares. Based on an average daily volume of 153,600 shares, the short-interest ratio is currently 24.8 days.January 30, 2025 | marketbeat.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Recommendation of "Buy" by AnalystsAchieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) has been given a consensus recommendation of "Buy" by the six ratings firms that are covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation toJanuary 29, 2025 | marketbeat.comAchieve Life Sciences, Inc. (ACHV): A Bull Case TheoryJanuary 24, 2025 | insidermonkey.comACHV Stock Touches 52-Week Low at $3.01 Amid Market ChallengesJanuary 21, 2025 | msn.comACHV: Long-Term Exposure Requirement CompleteJanuary 21, 2025 | msn.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Short Interest Up 30.0% in DecemberAchieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 3,810,000 shares, a growth of 30.0% from the December 15th total of 2,930,000 shares. Based on an average daily volume of 153,600 shares, the short-interest ratio is currently 24.8 days.January 16, 2025 | marketbeat.comAchieve Life Sciences appoints Slaoui, Phelan to board of directorsJanuary 11, 2025 | markets.businessinsider.comAchieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of DirectorsJanuary 10, 2025 | financialpost.comAchieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of DirectorsJanuary 10, 2025 | globenewswire.comOppenheimer Sticks to Its Buy Rating for Achieve Life Sciences (ACHV)January 9, 2025 | markets.businessinsider.comAchieve Life Sciences reaches milestone for ORCA-OL cytisinicline trialJanuary 8, 2025 | markets.businessinsider.comAchieve Life Sciences (ACHV) Gets a Buy from JonesTradingJanuary 8, 2025 | markets.businessinsider.comAchieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA SubmissionJanuary 7, 2025 | globenewswire.comAchieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference WeekJanuary 6, 2025 | globenewswire.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Average Rating of "Buy" from AnalystsAchieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) has been given a consensus rating of "Buy" by the six research firms that are covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buJanuary 4, 2025 | marketbeat.comInstitutional shareholders may be less affected by Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) pullback last week after a year of 0.5% returnsDecember 22, 2024 | uk.finance.yahoo.comFranklin Resources Inc. Reduces Stock Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV)Franklin Resources Inc. decreased its stake in shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) by 36.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,871,349 shares of the biopharmaceutical companDecember 20, 2024 | marketbeat.comAchieve Life Sciences Appoints Mark K. Oki as CFODecember 10, 2024 | markets.businessinsider.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Given Average Recommendation of "Buy" by AnalystsAchieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) has been given an average rating of "Buy" by the six research firms that are covering the firm, MarketBeat reports. Four investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company.December 10, 2024 | marketbeat.comAchieve Life Sciences Appoints Mark Oki As New CFODecember 9, 2024 | markets.businessinsider.comAchieve Life Sciences Appoints Mark Oki as Chief Financial OfficerDecember 9, 2024 | financialpost.comAchieve Life Sciences Appoints Mark Oki as Chief Financial OfficerDecember 9, 2024 | globenewswire.comAchieve Life Sciences announces outcome of End-of-Phase 2 meeting with FDADecember 3, 2024 | markets.businessinsider.comAchieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDADecember 3, 2024 | globenewswire.comShort Interest in Achieve Life Sciences, Inc. (NASDAQ:ACHV) Decreases By 9.6%Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 3,000,000 shares, a decline of 9.6% from the October 31st total of 3,320,000 shares. Based on an average daily trading volume, of 107,500 shares, the days-to-cover ratio is currently 27.9 days.December 1, 2024 | marketbeat.comSmoking Cessation Pipeline Insight 2024, with Focus on Emerging Drugs Cytisinicline (Achieve Life Sciences), EMB-001(Embera Pharmaceuticals) and SBP-9330 (Camino Pharma)November 25, 2024 | globenewswire.comAchieve Life Sciences initiated with a Buy at Rodman & RenshawNovember 15, 2024 | markets.businessinsider.comRodman & Renshaw Initiates Coverage of Achieve Life Sciences (ACHV) with Buy RecommendationNovember 15, 2024 | msn.comAchieve Life Sciences (NASDAQ:ACHV) Upgraded to Strong-Buy at RODMAN&RENSHAWRODMAN&RENSHAW upgraded Achieve Life Sciences to a "strong-buy" rating in a research report on Thursday.November 15, 2024 | marketbeat.comAchieve Life Sciences Announces Participation at Upcoming Investor ConferencesNovember 14, 2024 | globenewswire.comAchieve Life Sciences (NASDAQ:ACHV) Now Covered by Rodman & RenshawRodman & Renshaw assumed coverage on shares of Achieve Life Sciences in a report on Thursday. They issued a "buy" rating and a $12.00 target price on the stock.November 14, 2024 | marketbeat.comEquities Analysts Set Expectations for ACHV FY2024 EarningsAchieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Equities research analysts at Zacks Small Cap reduced their FY2024 earnings per share (EPS) estimates for shares of Achieve Life Sciences in a research report issued on Monday, November 11th. Zacks Small Cap analyst J. Vandermosten now forNovember 13, 2024 | marketbeat.comACHV: Commercialization in FocusNovember 12, 2024 | finance.yahoo.comAchieve Life Sciences Poised for U.S. Launch of Cytisinicline with Strong Financial and Strategic FoundationsNovember 12, 2024 | markets.businessinsider.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | msn.comAchieve Life Sciences: Promising Future with Strategic Leadership and Strong Financial Position Justifies Buy RatingNovember 10, 2024 | markets.businessinsider.comAchieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...November 9, 2024 | finance.yahoo.comAchieve Life Sciences, Inc. (ACHV) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comAchieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate UpdateNovember 8, 2024 | markets.businessinsider.comAchieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving Average - Time to Sell?Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200-Day Moving Average - What's Next?November 8, 2024 | marketbeat.comAchieve Life Sciences Q3 2024 Earnings PreviewNovember 6, 2024 | msn.comAchieve Life Sciences (ACHV) to Release Earnings on ThursdayAchieve Life Sciences (NASDAQ:ACHV) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639706)October 31, 2024 | marketbeat.comAchieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200-Day Moving Average - Here's WhyOctober 29, 2024 | marketbeat.com Get Achieve Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter. Email Address ACHV Media Mentions By Week ACHV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACHV News Sentiment▼0.950.60▲Average Medical News Sentiment ACHV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACHV Articles This Week▼13▲ACHV Articles Average Week Get Achieve Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RIGL News CDXS News XOMA News IRWD News VSTM News VNDA News SGMO News LXRX News AGEN News RGLS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACHV) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achieve Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Achieve Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
